Clodronic acid

Clodronic acid (also known as clodronate) is a biphosphonate drug used to treat osteoporosis and for the treatment of hypercalcemia. It is typically prescribed to postmenopausal women and is effective in reducing the risk of fractures due to osteoporosis. In addition, it is used to reduce bone pain and other symptoms associated with bone metastasis from breast cancer and prostate cancer. Clodronic acid works by inhibiting the action of osteoclasts, the cells that break down bone. This leads to an increase in bone mineral density, thereby reducing the risk of fractures.

Clodronic acid is a first-generation bisphosphonate medication primarily used to treat bone-related conditions caused by various factors. Here's a detailed description:

Function:

  • Inhibits the activity of osteoclasts, cells responsible for breaking down bone tissue.
  • This helps to:
    • Increase bone mineral density and reduce the risk of fractures in conditions like osteoporosis.
    • Control abnormal bone breakdown associated with hypercalcemia of malignancy (high blood calcium levels due to cancer).
    • Reduce bone pain and manage skeletal metastases (cancer spread to bones).

Applications:

  • Osteoporosis: Primarily used in postmenopausal women and men to prevent and treat osteoporosis and reduce the risk of vertebral fractures.
  • Hypercalcemia of malignancy: Manages abnormally high blood calcium levels caused by some types of cancer.
  • Paget's disease of bone: May be used in some cases to manage this rare bone disorder.

Administration:

  • Typically administered as an intravenous (IV) infusion over at least 2 hours.
  • Oral formulations exist, but their use is less common due to lower efficacy and potential gastrointestinal side effects.

Important Notes:

  • Not FDA-approved in the United States but approved for use in other countries like Canada, Australia, and the UK.
  • Generally well-tolerated but can cause side effects like:
    • Kidney problems
    • Low blood calcium levels (hypocalcemia)
    • Flu-like symptoms
    • Gastrointestinal issues (mainly with oral formulations)
  • Not recommended for pregnant or breastfeeding women and individuals with certain health conditions.
Anatomical Therapeutic Chemical Classification
M - Musculo-skeletal system
M05 Drugs for treatment of bone diseases
M05B - Drugs affecting bone structure and mineralization
M05BA Bisphosphonates
External Links